RESI London
8-9 December 2025, Virtual
The Redefining Every Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI is uniquely cross-border and cross-domain, connecting start-ups with global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare companies.
RESI London and Gensis are combining to offer a multi-day investment, partnering and thought leadership event for venture stage companies seeking funding and strategic alliances
More information, here.
AseBio members are eligible for a £200 discount.